http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017032089-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_268be9afa00cf55b5aa72b1612151ecb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-01
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H30-20
filingDate 2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5bc201622491b802277030453525bbb
publicationDate 2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2017032089-A1
titleOfInvention Medical support apparatus and system, and method of operating medical support apparatus
abstract A medical support apparatus includes a grouping unit for grouping plural lesions of a patient body treated by an anticancer chemotherapy into plural groups according to clinical onsets of the lesions. An information generator creates therapeutic effect information of therapeutic effect of the anticancer chemotherapy for respectively the plural groups. An information provider provides the therapeutic effect information. Preferably, assuming that the anticancer chemotherapy for the patient body is performed in plural therapy sessions, the groups are defined with reference to starting dates of respectively the plural therapy sessions of the anticancer chemotherapy. The lesion is further grouped (sub-grouped) according to at least one of a body organ where the lesion has occurred, and a lesion type of the lesion.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019113508-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3899988-A4
priorityDate 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012130223-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005113651-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007014454-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017124709-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284558

Total number of triples: 38.